{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:29:57Z","timestamp":1789766997282,"version":"4.0.1"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.pcad.2020.08.003","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T11:30:48Z","timestamp":1597231848000},"page":"111-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Medication adherence: Importance, issues and policy: A policy statement from the American Heart Association"],"prefix":"10.1016","volume":"64","author":[{"given":"Ileana L.","family":"Pi\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Di Palo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niteesh K.","family":"Choudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Cvengros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie P.","family":"Whitsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janay","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pcad.2020.08.003_bb0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.amjms.2016.01.010","article-title":"Medication adherence: truth and consequences","volume":"351","author":"Brown","year":"2016","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.pcad.2020.08.003_bb0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1472-6963-12-98","article-title":"Unintentional non-adherence to chronic prescription medications: how unintentional is it really?","volume":"12","author":"Gadkari","year":"2012","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"10.1016\/j.pcad.2020.08.003_bb0015","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1161\/CIR.0000000000000758","article-title":"The American Heart Association 2030 impact goal: a presidential advisory from the American Heart Association","volume":"141","author":"Angell","year":"2020","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.pcad.2020.08.003_bb0020","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","article-title":"Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients","volume":"120","author":"Mazzaglia","year":"2009","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.pcad.2020.08.003_bb0025","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2020.08.003_bb0030","first-page":"54","article-title":"Outcomes associated with primary and secondary nonadherence to cholesterol medications","volume":"8","author":"Lee","year":"2016","journal-title":"Am J Pharm"},{"key":"10.1016\/j.pcad.2020.08.003_bb0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/PPA.S29549","article-title":"Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions","volume":"7","author":"Hugtenburg","year":"2013","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"10.1016\/j.pcad.2020.08.003_bb0040","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pcad.2020.08.003_bb0045","first-page":"499","article-title":"Evaluating medication adherence: which measure is right for your program?","volume":"6","author":"Fairman","year":"2000","journal-title":"J Manag Care Pharm"},{"issue":"6","key":"10.1016\/j.pcad.2020.08.003_bb0050","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","author":"Farmer","year":"1999","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.pcad.2020.08.003_bb0055","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","article-title":"Predictive validity of a medication adherence measure in an outpatient setting","volume":"10","author":"Morisky","year":"2008","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"10.1016\/j.pcad.2020.08.003_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med Care"},{"issue":"7\u20138","key":"10.1016\/j.pcad.2020.08.003_bb0065","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1345\/aph.1H018","article-title":"Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.pcad.2020.08.003_bb0070","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ahj.2013.02.011","article-title":"Gender and racial disparities in adherence to statin therapy: a meta-analysis","volume":"165","author":"Lewey","year":"2013","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.pcad.2020.08.003_bb0075","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.pcad.2020.08.003_bb0080","first-page":"e22","article-title":"Effect of medication dosing frequency on adherence in chronic diseases","volume":"15","author":"Saini","year":"2009","journal-title":"Am J Manag Care"},{"issue":"3","key":"10.1016\/j.pcad.2020.08.003_bb0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10865-007-9147-y","article-title":"The impact of medication regimen factors on adherence to chronic treatment: a review of literature","volume":"31","author":"Ingersoll","year":"2008","journal-title":"J Behav Med"},{"issue":"11","key":"10.1016\/j.pcad.2020.08.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2011.05.028","article-title":"Trouble getting started: predictors of primary medication nonadherence","volume":"124","author":"Fischer","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2020.08.003_bb0095","article-title":"Patient adherence and medical treatment outcomes: a meta-analysis","volume":"40","author":"DiMatteo","year":"2002","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.pcad.2020.08.003_bb0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/hsw\/36.4.249","article-title":"Adherence to medication regimens among low-income patients with multiple comorbid chronic conditions","volume":"36","author":"Mishra","year":"2011","journal-title":"Health Soc Work"},{"issue":"12","key":"10.1016\/j.pcad.2020.08.003_bb0105","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s11606-011-1825-3","article-title":"A systematic review of adherence to cardiovascular medications in resource-limited settings","volume":"26","author":"Bowry","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.pcad.2020.08.003_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1377\/hlthaff.2009.1087","article-title":"Medication adherence leads to lower health care use and costs despite increased drug spending","volume":"30","author":"Roebuck","year":"2011","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"10.1016\/j.pcad.2020.08.003_bb0115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jacc.2016.11.034","article-title":"Improving medication adherence in cardiometabolic disease: practical and regulatory implications","volume":"69","author":"Ferdinand","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2020.08.003_bb0120","series-title":"Adherence to long-term therapies: Evidence for action","author":"Sabat\u00e9","year":"2003"},{"key":"10.1016\/j.pcad.2020.08.003_bb0125","first-page":"35","article-title":"Adherence and health care costs","volume":"7","author":"Iuga","year":"2014","journal-title":"Risk Manag Healthc Policy"},{"issue":"16","key":"10.1016\/j.pcad.2020.08.003_bb0130","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/archinte.1993.00410160029002","article-title":"Recall of recommendations and adherence to advice among patients with chronic medical conditions","volume":"153","author":"Kravitz","year":"1993","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.pcad.2020.08.003_bb0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamacardio.2018.4936","article-title":"Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease","volume":"4","author":"Rodriguez","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2020.08.003_bb0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2261-6-48","article-title":"Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease","volume":"6","author":"Ho","year":"2006","journal-title":"BMC Cardiovasc Disord"},{"issue":"38","key":"10.1016\/j.pcad.2020.08.003_bb0145","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/eurheartj\/eht219","article-title":"Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study","volume":"34","author":"Herttua","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.pcad.2020.08.003_bb0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/STROKEAHA.109.566950","article-title":"Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke","volume":"41","author":"Glader","year":"2010","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.pcad.2020.08.003_bb0155","first-page":"239","article-title":"Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations","volume":"12","author":"Bramley","year":"2006","journal-title":"J Manag Care Pharm"},{"issue":"6","key":"10.1016\/j.pcad.2020.08.003_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006056","article-title":"Antihypertensive medication adherence and risk of cardiovascular disease among older adults: a Population-Based Cohort Study","volume":"6","author":"Yang","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"10.1016\/j.pcad.2020.08.003_bb0165","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"The SPRINT Research Group","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.pcad.2020.08.003_bb0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/CIR.0000000000000228","article-title":"Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association","volume":"132","author":"Havranek","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pcad.2020.08.003_bb0175","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/HYPERTENSIONAHA.116.07905","article-title":"Research needs to improve hypertension treatment and control in African Americans","volume":"68","author":"Whelton","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2020.08.003_bb0180","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6536e1","article-title":"Vital signs: disparities in antihypertensive medication nonadherence among Medicare part D beneficiaries\u2014United States, 2014","volume":"65","author":"Ritchey","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.pcad.2020.08.003_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pec.2010.04.030","article-title":"Association of age, health literacy, and medication management strategies with cardiovascular medication adherence","volume":"81","author":"Kripalani","year":"2010","journal-title":"Patient Educ Couns"},{"issue":"3","key":"10.1016\/j.pcad.2020.08.003_bb0190","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF01857875","article-title":"Personality and patient adherence: correlates of the five-factor model in renal dialysis","volume":"18","author":"Christensen","year":"1995","journal-title":"J Behav Med"},{"key":"10.1016\/j.pcad.2020.08.003_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.pcad.2020.08.003_bb0200","doi-asserted-by":"crossref","DOI":"10.1080\/08870449908407311","article-title":"The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"Horne","year":"1999","journal-title":"Psychol Health"},{"issue":"3","key":"10.1016\/j.pcad.2020.08.003_bb0210","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2015.7667","article-title":"Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis","volume":"176","author":"Thakkar","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.pcad.2020.08.003_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/HYPERTENSIONAHA.109.132688","article-title":"Triple fixed-dose combination therapy: back to the past","volume":"54","author":"Black","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2020.08.003_bb0220","series-title":"4th annual ed. Generic Pharmaceutical Association","article-title":"Generic drug savings in the US","year":"2012"},{"key":"10.1016\/j.pcad.2020.08.003_bb0225","first-page":"83","article-title":"Why do the same drugs look different? Pills, trade dress, and public health","volume":"365","author":"Greene","year":"2011","journal-title":"Mass Medical Soc"},{"issue":"3","key":"10.1016\/j.pcad.2020.08.003_bb0230","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/2013.jamainternmed.997","article-title":"Variations in pill appearance of antiepileptic drugs and the risk of nonadherence","volume":"173","author":"Kesselheim","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.pcad.2020.08.003_bb0235","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7326\/M13-2381","article-title":"Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies","volume":"161","author":"Kesselheim","year":"2014","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.pcad.2020.08.003_bb0240","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/her\/cyv009","article-title":"Elder and caregiver solutions to improve medication adherence","volume":"30","author":"O'quin","year":"2015","journal-title":"Health Educ Res"},{"issue":"6","key":"10.1016\/j.pcad.2020.08.003_bb0245","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1037\/a0016087","article-title":"Patient preference for and reports of provider behavior: impact of symmetry on patient outcomes","volume":"28","author":"Cvengros","year":"2009","journal-title":"Health Psychol"},{"issue":"3","key":"10.1016\/j.pcad.2020.08.003_bb0250","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1207\/s15324796abm2703_3","article-title":"The role of perceived control and preference for control in adherence to a chronic medical regimen","volume":"27","author":"Cvengros","year":"2004","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.pcad.2020.08.003_bb0255","series-title":"Through the patient's eyes: Understanding and promoting patient-centered care","author":"Gerteis","year":"1993"},{"issue":"8","key":"10.1016\/j.pcad.2020.08.003_bb0260","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/MLR.0b013e31819a5acc","article-title":"Physician communication and patient adherence to treatment: a meta-analysis","volume":"47","author":"Zolnierek","year":"2009","journal-title":"Med Care"},{"issue":"7167","key":"10.1016\/j.pcad.2020.08.003_bb0265","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.317.7167.1202","article-title":"Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk","volume":"317","author":"Kinmonth","year":"1998","journal-title":"Bmj."},{"issue":"2","key":"10.1016\/j.pcad.2020.08.003_bb0270","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0738-3991(97)00089-X","article-title":"Randomized trial of a patient-centered hospital unit","volume":"34","author":"Martin","year":"1998","journal-title":"Patient Educ Couns"},{"issue":"16","key":"10.1016\/j.pcad.2020.08.003_bb0275","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/archinte.165.16.1842","article-title":"Posthospital medication discrepancies: prevalence and contributing factors","volume":"165","author":"Coleman","year":"2005","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.pcad.2020.08.003_bb0280","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s11606-012-2168-4","article-title":"Medication reconciliation accuracy and patient understanding of intended medication changes on hospital discharge","volume":"27","author":"Ziaeian","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"14","key":"10.1016\/j.pcad.2020.08.003_bb0285","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archinternmed.2012.2246","article-title":"Hospital-based medication reconciliation practices: a systematic review","volume":"172","author":"Mueller","year":"2012","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.pcad.2020.08.003_bb0290","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jama.297.8.831","article-title":"Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care","volume":"297","author":"Kripalani","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2020.08.003_bb0295","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/341759","article-title":"Assessing origins of quality gaps in discharge summaries: a survey of resident physician attitudes","volume":"2015","author":"Otto","year":"2015","journal-title":"Journal of biomedical education"},{"issue":"8","key":"10.1016\/j.pcad.2020.08.003_bb0300","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jhm.2021","article-title":"Comprehensive quality of discharge summaries at an academic medical center","volume":"8","author":"Horwitz","year":"2013","journal-title":"J Hosp Med"},{"issue":"4","key":"10.1016\/j.pcad.2020.08.003_bb0305","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCOUTCOMES.111.000101","article-title":"Hospital strategies associated with 30-day readmission rates for patients with heart failure","volume":"6","author":"Bradley","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"10.1016\/j.pcad.2020.08.003_bb0310","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2105\/AJPH.93.4.635","article-title":"Primary care: is there enough time for prevention?","volume":"93","author":"Yarnall","year":"2003","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.pcad.2020.08.003_bb0315","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamainternmed.2015.8597","article-title":"Polypharmacy\u2014time to get beyond numbers","volume":"176","author":"Steinman","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"22","key":"10.1016\/j.pcad.2020.08.003_bb0320","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/CIRCULATIONAHA.115.010268","article-title":"Current state of value-based purchasing programs","volume":"133","author":"Chee","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.08.003_bb0325","series-title":"20 major health systems, payers pledge to convert 75% of business to value-based arrangements by 2020","author":"Rappleye","year":"2015"},{"issue":"3","key":"10.1016\/j.pcad.2020.08.003_bb0330","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1331\/JAPhA.2014.13180","article-title":"Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality","volume":"54","author":"Academy of Managed Care Pharmacy, American Pharmacists Association","year":"2014","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.pcad.2020.08.003_bb0335","series-title":"Medication therapy management in chronically ill populations","author":"Perlroth","year":"2013"},{"key":"10.1016\/j.pcad.2020.08.003_bb0340","series-title":"A treatable problem: Addressing medication nonadherence by reorming government barriers to care coordination","author":"Prescriptions for a Healthy America","year":"2017"},{"issue":"1","key":"10.1016\/j.pcad.2020.08.003_bb0345","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3122\/jabfm.2015.01.140123","article-title":"The impact of health coaching on medication adherence in patients with poorly controlled diabetes, hypertension, and\/or hyperlipidemia: a randomized controlled trial","volume":"28","author":"Thom","year":"2015","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.pcad.2020.08.003_bb0350","series-title":"Health system transformation: Revisiting the federal anti-kickback statute adn physician self-referral (stark) law to foster integrated care delivery and payment models","author":"Healthcare Leadership Council","year":"2017"},{"key":"10.1016\/j.pcad.2020.08.003_bb0355","first-page":"1","article-title":"Strategies used by adults to reduce their prescription drug costs","volume":"119","author":"Cohen","year":"2013","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.pcad.2020.08.003_bb0360","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MLR.0b013e3181c132ad","article-title":"Patient, physician, and payment predictors of statin adherence","author":"Chan","year":"2010","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.pcad.2020.08.003_bb0365","first-page":"45","article-title":"How patient cost-sharing trends affect adherence and outcomes: a literature review","volume":"37","author":"Eaddy","year":"2012","journal-title":"Pharm Ther"},{"issue":"11","key":"10.1016\/j.pcad.2020.08.003_bb0370","first-page":"1247","article-title":"Examination of the link between medication adherence and use of mail-order pharmacies in chronic disease states","volume":"22","author":"Fernandez","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"issue":"7","key":"10.1016\/j.pcad.2020.08.003_bb0375","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jama.290.7.953","article-title":"Patient-physician communication about out-of-pocket costs","volume":"290","author":"Alexander","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pcad.2020.08.003_bb0380","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/M14-2427","article-title":"Improving adherence to therapy and clinical outcomes while containing costs: opportunities from the greater use of generic medications: best practice advice from the Clinical Guidelines Committee of the American College of Physicians","volume":"164","author":"Choudhry","year":"2016","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.pcad.2020.08.003_bb0385","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.mlr.0000163641.86870.af","article-title":"Impact of medication adherence on hospitalization risk and healthcare cost","volume":"43","author":"Sokol","year":"2005","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.pcad.2020.08.003_bb0390","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jamainternmed.2013.1539","article-title":"Physician acquiescence to patient demands for brand-name drugs: results of a national survey of physicians","volume":"173","author":"Campbell","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.pcad.2020.08.003_bb0395","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/jhh.2008.84","article-title":"Do socioeconomic disparities affect accessing and keeping antihypertensive drug therapy? Evidence from an Italian population-based study","volume":"23","author":"Corrao","year":"2009","journal-title":"J Hum Hypertens"},{"issue":"2","key":"10.1016\/j.pcad.2020.08.003_bb0400","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2337\/diacare.27.2.384","article-title":"Problems paying out-of-pocket medication costs among older adults with diabetes","volume":"27","author":"Piette","year":"2004","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.pcad.2020.08.003_bb0405","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/archinte.165.15.1749","article-title":"The role of patient-physician trust in moderating medication nonadherence due to cost pressures","volume":"165","author":"Piette","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2020.08.003_bb0410","author":"Center for Value-Based Insurance Design"},{"issue":"1","key":"10.1016\/j.pcad.2020.08.003_bb0415","first-page":"34","article-title":"Moving branded statins to lowest copay tier improves patient adherence","volume":"20","author":"Chen","year":"2014","journal-title":"J Manag Care Pharm"},{"issue":"2","key":"10.1016\/j.pcad.2020.08.003_bb0420","first-page":"141","article-title":"Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications","volume":"20","author":"Clark","year":"2014","journal-title":"J Manag Care Pharm"},{"issue":"2","key":"10.1016\/j.pcad.2020.08.003_bb0425","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1377\/hlthaff.2013.0260","article-title":"Value-based insurance design program in north Carolina increased medication adherence but was not cost neutral","volume":"33","author":"Maciejewski","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"8","key":"10.1016\/j.pcad.2020.08.003_bb0430","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1377\/hlthaff.2015.1456","article-title":"A synchronized prescription refill program improved medication adherence","volume":"35","author":"Doshi","year":"2016","journal-title":"Health Aff"},{"issue":"9","key":"10.1016\/j.pcad.2020.08.003_bb0435","first-page":"814","article-title":"The implications of therapeutic complexity on adherence to cardiovascular medications","volume":"171","author":"Choudhry","year":"2011","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.pcad.2020.08.003_bb0440","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ahj.2011.06.007","article-title":"Medication adherence: a call for action","volume":"162","author":"Bosworth","year":"2011","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.pcad.2020.08.003_bb0445","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1377\/hlthaff.2017.0881","article-title":"Medication synchronization programs improve adherence to cardiovascular medications and health care use","volume":"37","author":"Krumme","year":"2018","journal-title":"Health Aff"},{"issue":"11","key":"10.1016\/j.pcad.2020.08.003_bb0450","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1377\/hlthaff.2013.0539","article-title":"Expanding primary care capacity by reducing waste and improving the efficiency of care","volume":"32","author":"Shipman","year":"2013","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"10.1016\/j.pcad.2020.08.003_bb0455","first-page":"11","article-title":"A streamlined approach to prescription management","volume":"19","author":"Sinsky","year":"2012","journal-title":"Fam Pract Manag"},{"issue":"10","key":"10.1016\/j.pcad.2020.08.003_bb0460","doi-asserted-by":"crossref","first-page":"700","DOI":"10.7326\/0003-4819-157-10-201211200-00006","article-title":"Pharmacy dispensing of electronically discontinued medications","volume":"157","author":"Allen","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.pcad.2020.08.003_bb0465","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1056\/NEJMp1603964","article-title":"Incorporating indications into medication ordering \u2014 time to enter the age of reason","volume":"375","author":"Schiff","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.pcad.2020.08.003_bb0470","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11936-017-0560-4","article-title":"Digital health technologies to promote lifestyle change and adherence","volume":"19","author":"Khan","year":"2017","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.pcad.2020.08.003_bb0475","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamainternmed.2018.0447","article-title":"Association of a smartphone application with medication adherence and blood pressure control: the MedISAFE-BP randomized clinical trial","volume":"178","author":"Morawski","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.pcad.2020.08.003_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/mhealth.2017.11.01","article-title":"Pilot study of a smartphone application designed to socially motivate cardiovascular disease patients to improve medication adherence","volume":"4","author":"Fujita","year":"2018","journal-title":"Mhealth"},{"issue":"12","key":"10.1016\/j.pcad.2020.08.003_bb0485","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIR.0000000000000232","article-title":"Current science on consumer use of mobile health for cardiovascular disease prevention: a scientific statement from the American Heart Association","volume":"132","author":"Burke","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.08.003_bb0490","series-title":"The medication adherence roadmap: A path forward","author":"Network for Excellence in Health Innovation","year":"2011"},{"issue":"1","key":"10.1016\/j.pcad.2020.08.003_bb0495","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/M18-0543","article-title":"ESPACOMP medication adherence reporting guideline (EMERGE)","volume":"169","author":"De Geest","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2020.08.003_bb0500","doi-asserted-by":"crossref","first-page":"217047","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed Res Int"},{"issue":"11","key":"10.1016\/j.pcad.2020.08.003_bb0505","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-157-11-201212040-00538","article-title":"Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review","volume":"157","author":"Viswanathan","year":"2012","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.pcad.2020.08.003_bb0510","first-page":"775","article-title":"Understanding and overcoming barriers to medication adherence: a review of research priorities","volume":"20","author":"Seabury","year":"2014","journal-title":"J Manag Care Spec Pharm"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062020301559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062020301559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:18:25Z","timestamp":1758500305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062020301559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":101,"alternative-id":["S0033062020301559"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2020.08.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication adherence: Importance, issues and policy: A policy statement from the American Heart Association","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2020.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}